Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

Clinical Trial Description

Same as above ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Sinus Disease

See also
Status	Clinical Trial	Phase
Completed	`NCT05596084` - Comparison of the Use of Bovine Bone Graft and Titanium-Platelet Rich Fibrin in Maxillary Sinus Augmentation	N/A
Recruiting	`NCT05454072` - Microbiota Transfer for Chronic Rhinosinusitis	N/A
Not yet recruiting	`NCT06456255` - Bupivacaine and Epinephrine Injection Study	Phase 2/Phase 3
Recruiting	`NCT05607888` - Prospective Study of Sinonasal and Skull-base Tumours Management

See also

Status

Clinical Trial

Phase

Completed

NCT05596084 - Comparison of the Use of Bovine Bone Graft and Titanium-Platelet Rich Fibrin in Maxillary Sinus Augmentation

N/A

Recruiting

NCT05454072 - Microbiota Transfer for Chronic Rhinosinusitis

N/A

Not yet recruiting

NCT06456255 - Bupivacaine and Epinephrine Injection Study

Phase 2/Phase 3

Recruiting

NCT05607888 - Prospective Study of Sinonasal and Skull-base Tumours Management

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01222832
Study type	Interventional
Source	Steward St. Elizabeth's Medical Center of Boston, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	July 2010
Completion date	June 2012

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms